Company Active LTD

Company profile

Ludger Limited

Glycoprofiling Tools and Services | Ludger Ltd

Ludger Limited is a UK company with status active founded in 1999 based in South East England.

CRN
03803367
Founded
1999
Age
26

Overview

Legal name
LUDGER LIMITED
Region
South East England
Registered address
CULHAM SCIENCE CENTRE
ABINGDON
OXFORDSHIRE
OX14 3EB
Insolvency history
No

Latest accounts

Financial period: 1 Jan 2024 to 31 Dec 2024

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
26

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Sep
2026

Accounts due

Accounts Due

Next accounts due date

18 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

04 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

31 Dec
2024

Accounts filed

Accounts

Last accounts made up date

08 Jul
1999

Incorporated

Inception

Company registered at Companies House

Public funding

4 awards
First funded
2017
Funded years
2017, 2020, 2023
Age at first award
17 years

Projects

2023 EU-Funded Lead participant

GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION

1 Jan 2023 to 31 Dec 2028

Awarded
£196,815
Total cost £196,815

no public description

2020 Feasibility Studies Lead participant

GlyHealth-COVID: A precision medicine test to identify ImmunoFrail patients at high risk of becoming severely ill or dying from COVID-19

1 Jul 2020 to 31 Mar 2021

Awarded
£71,664
Total cost £71,664

This project is to accelerate the development of a proof-of-concept prototype of **GlyHealth-COVID** - a medical technology we are designing to identify '**immunofrail**' individuals who are at high risk of becoming severely ill or dying from COVID-19\. Initially, it was thought that only the elderly would get very sick and die from COVID-19 but around 25...

2020 Knowledge Transfer Network Lead participant

Hupela-PCOS-Filipina: A feasibility study for a lifestyle programme for women with polycystic ovary syndrome living in the Philippines

1 Apr 2020 to 30 Sep 2020

Awarded
£42,111
Total cost £84,221

This is a project to help women living with polycystic ovary syndrome (PCOS) in the Philippines. PCOS results from a hormonal imbalance that can lead to infertility, disordered menstrual cycle, masculinisation and weight gain. Long-term complications include diabetes and increased risk of ovarian cancer. PCOS is the major cause of female infertility in th...

2017 Feasibility Studies Lead participant

GlycanDx-MODY - a glycomics precision diagnostic assay for MODY diabetes

1 Feb 2017 to 31 Jan 2018

Awarded
£105,259
Total cost £150,370

GlycanDx-MODY is a test to identify patients with HNF1A-type Maturity Onset Diabetes of the Young (MODY). This is a type of diabetes affecting up to 4% of diabetics (40K-160K cases in the UK) that can be treated with inexpensive oral drugs. Most MODY patients are misdiagnosed and prescribed insulin, which does not treat their disease, is inconvenient and ...

Product types

EU-Funded Feasibility Studies Knowledge Transfer Network